NAMI HelpLine

Although major depressive disorder can be a challenging illness, it often responds to treatment. The key is to get a thorough evaluation and treatment plan. Safety planning is important for people who have thoughts of self-harm and/or suicide. After an assessment rules out medical and other possible causes, a person-centered treatment plan can include any one or a combination of the following:

  • Psychotherapy including cognitive behavioral therapy, family-focused therapy and interpersonal therapy
  • Medications including antidepressants, mood stabilizers and antipsychotic medications
  • Exercise can help with prevention and mild-to-moderate symptoms
  • Brain stimulation therapies can be used if psychotherapy and/or medication are not effective. These include electroconvulsive therapy (ECT) for depressive disorder with psychosis or repetitive transcranial magnetic stimulation (rTMS) for severe depression.
  • Light therapy, which requires specific kinds of light that can help with the seasonal dimension of depression for some people. These devices are not FDA approved.
  • Complementary and alternative approaches including acupuncture, meditation, faith and nutrition can be part of a comprehensive treatment plan
  • Innovative treatments for depression including ketamine and esketamine (Spravato)

Many treatment options are available for depression, but how well treatment works depends on the type of depression, its severity and the person themselves. For most people, a combination of psychotherapy and medication gives better results than either alone, but this is something to review with your mental health care provider.

Psychotherapy

Psychotherapy (or talk therapy) has an excellent track record of helping people with depressive disorder. While some types of psychotherapies have been researched more than others, many can be helpful and effective. A good relationship with a therapist can help improve outcomes.

Many clinicians are trained in more than one kind of psychotherapy, and it’s important to ask your clinician what kind of psychotherapy they practice and how it can help you. A few examples include:

  • Cognitive behavioral therapy (CBT) has a strong research base to show it helps with symptoms of depression. This structured therapy helps assess and change negative thinking patterns associated with depression. The goal of CBT is to recognize negative thoughts and learn new coping strategies. CBT is often time-limited and the number of sessions may vary from person to person.
  • Interpersonal therapy (IPT) focuses on improving problems in personal relationships that may be contributing to depressive disorder. Therapists teach individuals to evaluate their interactions and to improve how they relate to others. IPT is often time-limited like CBT.
  • Psychodynamic therapy is a therapeutic approach rooted in recognizing and understanding problems rooted in past experiences and working to resolve them. Looking at a person’s unconscious processes is another component of this psychotherapy. It can occur in short-term or longer-term sessions.

Psychoeducation and Support Groups

Psychoeducation involves teaching individuals about their illness, how to treat it and how to recognize signs that their symptoms may be coming back or worsening. Family psychoeducation is also helpful for family members who want to understand what their loved one is experiencing.

Support groups, meanwhile, offer participants an opportunity to share experiences and coping strategies. Support groups may be for the person with a mental health condition, for family/friends or both. Mental health professionals lead some support groups, but groups can also be peer-led.

Explore NAMI’s nationwide offerings of free, peer-led educational programs and support groups that provide outstanding education, skills training and support.

Medications

For some people, antidepressant medications may help reduce or manage symptoms. Antidepressants often take 2-4 weeks to begin having an effect and up to 12 weeks to reach full effect. Most people will have to try different doses and/or medications to find what works for them. It’s important to be aware that if there is an underlying bipolar condition, the use of antidepressant medications can initiate a manic episode. Sharing family history with the treating professional is important in identifying this and other potential risks. Here are some antidepressants commonly used to treat depression:

Selective serotonin reuptake inhibitors (SSRIs) act on serotonin, a brain chemical. They are the most common medications prescribed for depression.

Serotonin and norepinephrine reuptake inhibitors (SNRIs) increase serotonin and norepinephrine availability in the brain.

Norepinephrine-dopamine reuptake inhibitors (NDRIs) increase dopamine and norepinephrine. Bupropion (Wellbutrin) is a popular NDRI medication, which causes fewer (and different) side effects than other antidepressants. For some people, bupropion causes anxiety symptoms, but for others it is an effective treatment for anxiety.

Tetracyclic antidepressants, like Mirtazapine (Remeron), target serotonin and norepinephrine receptors in the brain, increasing the activity of several brain circuits. Mirtazapine is used less often than newer antidepressants (SSRIs, SNRIs and bupropion) because it is associated with more weight gain, sedation and sleepiness. However, it appears to be less likely to result in insomnia, sexual side effects and nausea than SSRIs and SNRIs.

Second-generation antipsychotics (SGAs), or “atypical antipsychotics,” treat schizophrenia, acute mania, bipolar disorder and bipolar mania and other mental illnesses. SGAs can be used for treatment-resistant depression.

Tricyclic antidepressants (TCAs) are older medications, rarely used today as initial treatment for depression. They work similarly to SNRIs but have more side effects. They are sometimes used when other antidepressants have not worked. TCAs may also ease chronic pain.

  • Amitriptyline (Elavil)
  • Desipramine (Norpramin)
  • Doxepin (Sinequan)
  • Imipramine (Tofranil)
  • Nortriptyline (Pamelor, Avantyl)
  • Protriptyline (Vivactil)

Monoamine oxidase inhibitors (MAOIs) are less used today because of newer medications with fewer side effects. These medications can never be used in combination with SSRIs. MAOIs can sometimes be effective for people who do not respond to other medications. There are also dietary restrictions associated with MAO inhibitors that should be discussed with your treatment professional.

Other medications have been developed in recent years and work differently than those traditionally used to treat depression. Each of the following are approved for use in MDD:

Brain Stimulation Therapies

For some, brain stimulation therapies may be effective, typically after other treatments have not been effective.

  • Electroconvulsive Therapy (ECT) involves transmitting short electrical impulses into the brain. ECT does cause some side effects, including memory loss. Individuals should understand the risks and benefits of this intervention before beginning a treatment trial.
  • Repetitive Transcranial Magnetic Stimulation (rTMS) is a relatively new type of brain stimulation that uses a magnet instead of an electrical current to activate the brain. It is not effective as a maintenance treatment. rTIMS is FDA approved for treatment-resistant depression.
  • Vagus Nerve Stimulation (VNS) has a complex history. For a fuller understanding of this treatment, read the NIMH summary of this and other brain stimulation interventions.
  • Deep Brain Stimulation. This treatment has been used to treat Parkinson’s disease. See the NIMH page on brain stimulation for more information.

Light Therapy

Light therapy involves sitting close to a specialized light box that generates intense artificial light to mimic sunlight. These devices can be helpful for depression with a seasonal dimension. Usually, people use them in the morning. Some devices are covered by insurance even though they are not FDA approved.

As with antidepressants, if you experience manic or hypomanic symptoms (rare with light therapy) this should be immediately discussed with your provider as bipolar disorder requires a different approach.

Complementary and Alternative Medicine (CAM)

Relying solely on CAM methods is not enough to treat depression, but they may be useful when combined with psychotherapy and medication. Discuss your ideas of CAM interventions with your health care professional to be sure they will not cause side effects or adverse reactions.

The National Center for Complementary and Integrative Health reviews research on complementary treatments. You can search for each intervention on their website.

  • Exercise. Studies show that aerobic exercise can help treat mild depression because it increases endorphins and stimulates norepinephrine, which can improve a person’s mood.
  • Folate. Some studies have shown that when people with depression lack folate (also called folic acid or vitamin B9), they may not be receiving the full benefit from any antidepressants they may be taking. Studies suggest that in some situations taking L-methylfolate (an active form of folate) can be an additional treatment with other psychiatric medications.
  • St John’s Wort. This supplement has similar chemical properties to some SSRIs. Risks of combining St John’s Wort with SSRIs and other medications are well-known and substantial.

Innovative Treatments for Depression

In recent years, new types of medications have emerged that offer hope for people whose depression has not improved with traditional treatments like SSRIs or therapy. One of the most promising is ketamine, along with a growing number of similar, fast-acting medications that target the brain in different ways. These treatments can be helpful for people with treatment-resistant depression, meaning they have not responded to at least two other antidepressants as well as those experiencing severe depressive symptoms or suicidal thoughts.

Ketamine and Esketamine (Spravato)

  • Ketamine is an anesthetic that, at lower doses, has been found to rapidly reduce symptoms of treatment-resistant depression, sometimes within hours. Ketamine is not approved for use in MDD by the FDA.
  • Esketamine is a nasal spray version of ketamine approved by the FDA for use in adults with treatment-resistant depression. It’s usually given in a clinic under medical supervision, alongside a traditional antidepressant.
  • These medications are thought to work by targeting the brain’s glutamate system, which is different from most antidepressants that act on serotonin, dopamine, or norepinephrine. There is also some evidence that these medications may promote brain growth and neuroplasticity.
  • Many patients report not just symptom relief but a shift in perspective that helps them feel more emotionally “unstuck.” These effects are typically shorter term.

Drug Administration

  • Ketamine is typically administered by intravenous (IV) infusion, while esketamine is given as a nasal spray in a certified treatment center.
  • Treatment is closely monitored due to the potential for side effects, such as dissociation, dizziness, or elevated blood pressure.

Other Emerging Therapies

  • Researchers are exploring psychedelic-assisted therapies, such as those using psilocybin (the active compound in “magic mushrooms”), for depression and other mental health conditions.
  • These treatments are still in clinical trials and not yet widely available, but early results are promising, especially when combined with therapy. They are not FDA approved as of the time of this page’s most recent update.

Reviewed and updated June 2025

NAMI HelpLine is available M-F, 10 a.m. – 10 p.m. ET. Call 800-950-6264,
text “NAMI” to 62640, or email. In a crisis, call or text 988 (24/7).